BENETOR PLUS 20mg/12.5mg and 20mg/25mg film-coated tablets *

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 09 June 2020

File name

Benetor-Plus-20mg-combined-SmPC~V14-020620-(IA choroidal effusion)-clean_1591714239.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Updated following Type IA Choroidal Effusion

Updated on 09 June 2020

File name

PIL-Benetor-Plus-20mg~V14-020620-(IA choroidal effusion)-clean_1591714128.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Free text change information supplied by the pharmaceutical company

Updated for Type IA Choroidal Effusion

Updated on 23 November 2018

File name

PIL-Benetor-Plus-20mg~V13-221118-(PRAC signal-NMSC & HCTZ)-clean_1542909587.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 22 November 2018

File name

Benetor-Plus-20mg-combined-SmPC~V13-221118-(PRAC signal-NMSC & HCTZ)-clean_1542907599.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 23 December 2016

File name

PIL_11420_323.pdf

Reasons for updating

  • New PIL for new product

Updated on 23 December 2016

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 22 July 2016

Reasons for updating

  • Change to storage instructions
  • Change to date of revision

Updated on 05 February 2015

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to drug interactions

Updated on 17 November 2014

Reasons for updating

  • Change to warnings or special precautions for use

Updated on 11 November 2014

Reasons for updating

  • Change to warnings or special precautions for use
  • Addition of information on reporting a side effect.

Updated on 28 July 2014

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to further information section

Updated on 21 December 2011

Reasons for updating

  • Change due to harmonisation of PIL

Updated on 11 October 2011

Reasons for updating

  • Improved electronic presentation

Updated on 21 April 2010

Reasons for updating

  • Change of contraindications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to marketing authorisation holder

Updated on 26 September 2006

Reasons for updating

  • Improved electronic presentation

Updated on 06 September 2006

Reasons for updating

  • Correction of spelling/typing errors

Updated on 04 September 2006

Reasons for updating

  • New PIL for new product